These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 11780906)

  • 1. Concomitant occurrence of macroprolactin, exercise-induced amenorrhea, and a pituitary lesion: a diagnostic pitfall. Case report.
    Cattaneo FA; Fahie-Wilson MN
    J Neurosurg; 2001 Aug; 95(2):334-7. PubMed ID: 11780906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with macroprolactinaemia: clinical and radiological features.
    Donadio F; Barbieri A; Angioni R; Mantovani G; Beck-Peccoz P; Spada A; Lania AG
    Eur J Clin Invest; 2007 Jul; 37(7):552-7. PubMed ID: 17576206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hook effect in prolactin immunoassays.
    Al Sifri SN; Raef H
    Saudi Med J; 2004 May; 25(5):656-9. PubMed ID: 15138537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia.
    Suliman AM; Smith TP; Gibney J; McKenna TJ
    Clin Chem; 2003 Sep; 49(9):1504-9. PubMed ID: 12928232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Some issues in the diagnosis and treatment of hyperprolactinemia].
    Jin ZM
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):241-3. PubMed ID: 18843959
    [No Abstract]   [Full Text] [Related]  

  • 7. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prolactin-secreting microadenoma in menopausal women].
    Barka I; Dendana E; Chikhrouhou N; Maroufi A; Kacem M; Chadli M; Ach K
    Pan Afr Med J; 2017; 27():177. PubMed ID: 28904704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macroprolactinemia in patients with prolactinomas: prevalence and clinical significance.
    Elenkova A; Genov N; Abadzhieva Z; Kirilov G; Vasilev V; Kalinov K; Zacharieva S
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):201-5. PubMed ID: 23595795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperprolactinaemia does not always mean 'hyperprolactinaemia'!
    Gezer A; Atasü T; Hekim C; Stenman UH; Hekim N
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):206-8. PubMed ID: 15653204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin and macroprolactin: a case report of hyperprolactinaemia highlighting the interpretation of discrepant results.
    Ismail AA; Walker PL; Fahie-Wilson MN; Jassam N; Barth JH
    Ann Clin Biochem; 2003 May; 40(Pt 3):298-300. PubMed ID: 12803849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI--diagnostic and follow-up tool for microprolactinomas.
    Seidl Z; Obenberger J; Marek J; Hána V; Vanĕcková M
    Funct Neurol; 2000; 15(1):47-51. PubMed ID: 10842760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Neutral Effect of Metformin Treatment on Macroprolactin Content in Women with Macroprolactinemia.
    Krysiak R; Szkróbka W; Okopień B
    Exp Clin Endocrinol Diabetes; 2017 Apr; 125(4):223-228. PubMed ID: 27750350
    [No Abstract]   [Full Text] [Related]  

  • 15. The diagnostic importance of prolactin subgroups in patients with stalk mass.
    Bagdatoglu C; Ay A; Bagdatoglu OT; Ozer C; Polat G; Koksel T
    Acta Neurochir (Wien); 2005 Feb; 147(2):209-10. PubMed ID: 15647889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prolactin and the laboratory].
    Veloza A; Prazeres S
    Acta Med Port; 2011 Dec; 24 Suppl 4():1029-34. PubMed ID: 22863514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Hook effect" in prolactinomas: case report and review of literature.
    Frieze TW; Mong DP; Koops MK
    Endocr Pract; 2002; 8(4):296-303. PubMed ID: 12173917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prolactinoma masked by a herbal remedy.
    Gallagher J; Lynch FW; Barragry J
    Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):257-8. PubMed ID: 17298863
    [No Abstract]   [Full Text] [Related]  

  • 19. Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas.
    Lewandowski KC; Gasior-Perczak D; Kowalska A; Lewinski A
    Gynecol Endocrinol; 2014 May; 30(5):385-7. PubMed ID: 24533748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of Macroprolactin in Hyperprolactinemia.
    Sherazi NA; Baig MZ; Khan AH
    J Coll Physicians Surg Pak; 2018 Feb; 28(2):93-97. PubMed ID: 29394965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.